相关实验视频

Updated: Sep 18, 2025

Quantitative Measurement of γ-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms

Quantitative Measurement of γ-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms

Published on: January 25, 2018

在阿尔茨海默氏病中准γ-分泌酶

Lin Du^1,2, Ge Li¹, Yinxiang Wei²

¹Beijing Institute of Basic Medical Sciences, Beijing, China.

Journal of Alzheimer's disease reports

|June 26, 2025

概括

阿尔茨海默病 (AD) 涉及粉样ββ (Aβ) 的积累. 针对产生Aβ的酶玛分泌酶,为AD治疗提供了一个有前途的治疗策略.

科学领域:

神经科学是一个神经科学.
生物化学生物化学
药理学药理学是指药理学的学科.

背景情况:

阿尔茨海默病 (AD) 是一种主要的神经退行性疾病,导致记忆力丧失和认知能力下降.
粉样蛋白级联假说表明有毒的粉样蛋白-β (Aβ) 的积累驱动AD的发病.
玛分泌酶是一种对Aβ产生至关重要的酶,是关键的治疗点.

研究的目的:

审查马分泌酶活性在阿尔茨海默氏症病原发生中的作用.
探索玛分泌酶抑制剂和调节剂的分子机制.
讨论在阿尔茨海默病治疗中准马分泌酶的未来前景.

主要方法:

关于玛分泌酶和阿尔茨海默病的研究文献综述.
对玛分泌酶抑制剂和调节剂的分子机制的分析.
讨论针对玛分泌酶的治疗策略.

主要成果:

马分泌酶在Aβ生产的最后一步中起着至关重要的作用.
已经开发出了选择性抑制剂和玛分泌酶调节剂.
准马分泌酶为AD干预提供了一个可行的策略.

结论:

马分泌酶是开发新型阿尔茨海默病治疗的重要目标.
对马分泌酶调节剂的进一步研究可能会产生有效的治疗方法.
准马分泌酶为对抗AD进展提供了新的途径.

关键词:

阿尔茨海默病的疾病阿尔茨海默病的疾病.它们是Aβ酸.粉胺-β类.神经退行症的神经退行症 γ-秘密的秘密 γ-分泌酶抑制剂的使用 γ-分泌酶调节器

更多相关视频

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Published on: March 7, 2019

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP

Published on: October 17, 2015

相关概念视频

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...